v3.26.1
Basis of Presentation and Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Summarizes the significant expense categories reviewed

The table below summarizes the significant expense categories reviewed by the CEO for the three months ended March 31, 2026 and 2025:

 

 

 

Three months ended
March 31,

 

 

 

2026

 

 

2025

 

Research and Development

 

 

 

 

 

 

Personnel

 

$

 

 

$

4

 

Stock-based compensation

 

 

 

 

 

15

 

Program expenses

 

 

 

 

 

26

 

Other unallocated expenses

 

 

15

 

 

 

48

 

Total research and development

 

 

15

 

 

 

93

 

General and Administrative

 

 

 

 

 

 

Personnel

 

 

502

 

 

 

314

 

Stock-based compensation

 

 

78

 

 

 

122

 

Professional fees

 

 

845

 

 

 

1,151

 

Other general and administrative

 

 

215

 

 

 

283

 

Total general and administrative

 

 

1,640

 

 

 

1,870

 

Other segment items

 

 

(49

)

 

 

(371

)

Net loss

 

$

1,606

 

 

$

1,592

 

Dilutive Securities Excluded from Computation of Diluted Weighted Average Shares of Common Stock Outstanding

The following potentially dilutive securities have been excluded from the computation of diluted weighted-average shares outstanding, as they would be anti-dilutive:

 

 

 

March 31,

 

 

 

2026

 

 

2025

 

Stock options

 

 

10,599,059

 

 

 

3,175,859

 

Common stock warrants

 

 

13,850,661

 

 

 

13,850,661

 

 

 

24,449,720

 

 

 

17,026,520